Document Name: role of Triethanolamine, 99% in Cold Cream2
Document link: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=f86b5de9-8e44-4d06-890e-75f7e71c79e4&type=display








AVERTEX Benzyl Alcohol 






AVERTEAX- benzyl alcohol  cream 
Camellix, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------

AVERTEX Benzyl Alcohol 





Active ingredient        Purpose
 Benzyl Alcohol (1.0%)     Cold Sores & Fever blisters




PURPOSE:
Treats cold sores and fever blisters, a vesicle that occurs at the junction of the mucous membrane and the skin on the lips or nose and is caused by the virus herpes simplex, type 1.





ASK DOCTOR:
If condition worsens or does not improve after regular use of the product as directed, consult a doctor.
If swallowed, contact a doctor.




WARNINGS:
For external use only.




DIRECTIONS:
For the temporary relief of pain and itching of cold sores and fever blisters, apply AverTeaX ointment directly on the affected area throughout the day as needed. To achieve best result, apply at the frist sign of symptons (redness, tingling, tightness, or itching.)




STOP USE:
If illergic to any ingridient of the product.




INDICATIONS & USAGE:
Indications are for pain and itching associated with fever blisters and cold sores.
For the temporary Relief of Pain and itching associated with fever blisters and cold sores.




DO NOT USE:
If allergic to any ingredient of the product.





KEEP OUT OF REACH OF CHILDREN:

Keep out of reach of children.
If swallowed, contact a doctor. 





INACTIVE INGREDIENT

Ultrez 10 (Carbopol), Cetyl Alcohol (Powder Form), Stearic Acid, E. Glycol Stearate (EGMS), Glyceryl Stearate (GMS), Safflower Oil, Propylene Glycol USP, Glycerin (USP Grade) 99.7%, PMX-200 Silicone Fluid, Euxyl PE 9010 (0.5% - 1.0%), Aloe Vera, EGCG (Epigallocatechin-3-Gallate, Extracted from Green Tea) Stearate, EGCG Palmitate, Eucalyptus oil, Sodium Hyaluronate (Hyaluronic Acid), Lutein 10% (Marigold Ext. 10%), TEA (Triethanolamine)(99%).




AVERTEAX TOPICAL OINTMENT COLD SORES AND FEVER BLISTERS TREATMENT DISTRIBUTED BY CAMELLIX MADE IN USA




  Principal display panal













AVERTEAX 		
					

benzyl alcohol  cream





Product Information


Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54866-002


Route of AdministrationTOPICAL








Active Ingredient/Active Moiety


Ingredient NameBasis of StrengthStrength


BENZYL ALCOHOL (UNII: LKG8494WBH)  (BENZYL ALCOHOL - UNII:LKG8494WBH) BENZYL ALCOHOL10 mg  in 1 g








Inactive Ingredients


Ingredient NameStrength


WATER (UNII: 059QF0KO0R)  


CARBOMER COPOLYMER TYPE A (UNII: 71DD5V995L)  


CETYL ALCOHOL (UNII: 936JST6JCN)  


STEARIC ACID (UNII: 4ELV7Z65AP)  


GLYCOL STEARATE (UNII: 0324G66D0E)  


GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  


Safflower Oil (UNII: 65UEH262IS)  


Propylene Glycol (UNII: 6DC9Q167V3)  


Glycerin (UNII: PDC6A3C0OX)  


DIMETHICONE (UNII: 92RU3N3Y1O)  


PHENOXYETHANOL (UNII: HIE492ZZ3T)  


ALOE VERA LEAF (UNII: ZY81Z83H0X)  


EPIGALLOCATECHIN GALLATE STEARATES (UNII: MGB2NQG22C)  


EPIGALLOCATECHIN GALLATE PALMITATES (UNII: M213AC47MB)  


EUCALYPTUS OIL (UNII: 2R04ONI662)  


Hyaluronic Acid (UNII: S270N0TRQY)  


LUTEIN (UNII: X72A60C9MT)  


CALENDULA OFFICINALIS FLOWER (UNII: P0M7O4Y7YD)  


TROLAMINE (UNII: 9O3K93S3TK)  











Packaging


#Item CodePackage DescriptionMarketing Start DateMarketing End Date


1NDC:54866-002-011  in 1 PACKAGE


17.4 g in 1 TUBE











Marketing Information


Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date


OTC monograph not finalpart34801/01/2014








Labeler - Camellix, LLC
							(968429386)
						




Establishment


NameAddressID/FEIBusiness Operations


Star Health and Beauty, LLC013506838manufacture(54866-002) 




Revised: 3/2014

Document Id: dea0cd6a-9743-4539-a694-c88cf3543525
Set id: f86b5de9-8e44-4d06-890e-75f7e71c79e4
Version: 1
Effective Time: 20140307

 Camellix, LLC



